Blog - Consumer Justice Foundation

Our Blog

Bayer and Johnson & Johnson Agree to Settle Xarelto Lawsuits for $775 Million

May 2, 2019

Pharmaceutical giants Bayer and Johnson & Johnson have agreed to pay $775 million to settle thousands of product liability lawsuits filed over problems with their blood thinner medication, Xarelto, which has been linked to an increased risk of stroke, bleeding problems and death. The settlement agreement resolves nearly 25,000 Xarelto state… Read More> Comments Off on Bayer and Johnson & Johnson Agree to Settle Xarelto Lawsuits for $775 Million

3M Earplug Lawsuits Continue to Mount Over Hearing Loss, Tinnitus, Other Hearing Problems

April 30, 2019

Thousands of military veterans and servicemembers are expected to pursue lawsuits against 3M Company over defective combat earplugs the company sold to the United States military, which they allege caused them to suffer hearing loss, tinnitus and other debilitating hearing problems. According to the 3M litigation, the government contractor knew that… Read More> Comments Off on 3M Earplug Lawsuits Continue to Mount Over Hearing Loss, Tinnitus, Other Hearing Problems

CA Jury Delivers $80.3 Million Verdict in Roundup Weed Killer Cancer Lawsuit

April 16, 2019

A federal jury in San Francisco awarded plaintiff Edwin Hardeman more than $80 million in damages late last month, after determining that exposure to the popular weed killer, Roundup, was a substantial factor in his development of cancer. According to Hardeman’s lawsuit, the California resident was diagnosed with non-Hodgkin’s lymphoma in… Read More> Comments Off on CA Jury Delivers $80.3 Million Verdict in Roundup Weed Killer Cancer Lawsuit

Roundup Lawsuits Continue to Mount Following Landmark $289 Million Verdict

September 6, 2018

Bayer, the new owner of Monsanto, the company responsible for manufacturing the controversial weed killer Roundup, reported last month that the number of lawsuits filed over side effects of Roundup exposure has skyrocketed to 8,000, following the recent $289.2 million Roundup verdict handed down in a California court. The…

Read More> Comments Off on Roundup Lawsuits Continue to Mount Following Landmark $289 Million Verdict

Nuplazid Patient Deaths

April 14, 2018

Reports of Deaths Linked to Parkinson’s Disease Psychosis Drug Spark Safety Concerns

Hundreds of patients have died while taking Nuplazid, a drug manufactured by San Diego-based Acadia Pharmaceuticals to control psychosis related to Parkinson’s disease, a debilitating movement disorder that affects hundreds of thousands of individuals and has a typical…

Read More> Comments Off on Nuplazid Patient Deaths

Multimillion-Dollar IVC Filter Verdict

April 13, 2018

$3.6 Million IVC Filter Verdict Good News for Plaintiffs in Thousands of Pending Lawsuits

A federal jury in Arizona just last week ordered medical device maker C.R. Bard to pay $3.6 million in compensatory and punitive damages in the first IVC filter lawsuit to go to trial. And while the…

Read More> Comments Off on Multimillion-Dollar IVC Filter Verdict

Roundup Cancer Litigation Update

April 9, 2018

MDL Judge Weighing Expert Testimony on Potential Link Between Roundup Weedkiller and Cancer

As product liability claims involving Roundup weed killer and non-Hodgkin’s lymphoma continue to be investigated by attorneys across the country, the federal judge presiding over all federal Roundup lawsuits will consider expert testimony presented by both sides…

Read More> Comments Off on Roundup Cancer Litigation Update
Start Claim Now
Do you deserve compensation?

An attorney will review your situation for FREE and help you found out what really went wrong.

How Can We Reach You?

Please Explain Your Situation

By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.
×